The NIHR Newcastle Biomedical Research Centre (BRC) has launched a new course to train the next generation of clinical researchers specialising in research with older people.
Clinicians from around the UK interested in research for older people attended the inaugural NIHR Newcastle BRC Introduction to Clinical Research for Older People course on the 11th of May 2019.. The delegates, drawn from geriatric medicine, psychiatry of old age and pharmacy, spent an intensive day learning about the research process, from reading the literature through to getting published. Interactive sessions gave delegates the opportunity to take part in critically appraising studies, designing a clinical trial and writing an abstract from a dataset against the clock.
“Getting the next generation of researchers interested is an important step in producing theresearch workforce that we need to deliver healthcare that is right for older people” said course director Professor Miles Witham, Professor of Trials for Older People at the NIHR Newcastle BRC. “The course is based on similar courses that we have run in Scotland before, but is focussed on clinical research with older people. It’s an ideal entry point for trainees and established clinicians who are interested in pursuing a career in research with older people, or who want to find out more about the basics before committing themselves”
Training the next generation of researchers
A multidisciplinary faculty, including research-active clinicians in geriatric medicine and psychiatry of old age delivered the course, covering topics including the research process, public and participant engagement, study design, obtaining governance and ethics approvals, project management, data management, analysis and dissemination.
The course was well received by delegates and the BRC plans to run the course annually. “The demand is certainly there for courses of this nature” commented Professor Witham, “and training the next generation of clinical researchers is a key plank of our BRC strategy to deliver translational research to benefit older people and those with long-term conditions”.